[HTML][HTML] Phase II trial of adjuvant dendritic cell vaccine in combination with celecoxib, interferon-α, and rintatolimod in patients undergoing cytoreductive surgery and …
R Ramanathan, H Choudry, H Jones, M Girgis… - Annals of Surgical …, 2021 - Springer
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and …
R Ramanathan, H Choudry, H Jones… - Annals of surgical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and …
R Rajesh, C Haroon, H Jones, M Girgis… - Annals of Surgical …, 2021 - search.proquest.com
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
[HTML][HTML] Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery …
R Ramanathan, H Choudry, H Jones… - Annals of Surgical …, 2021 - ncbi.nlm.nih.gov
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and …
R Ramanathan, H Choudry, H Jones… - Annals of Surgical …, 2021 - europepmc.org
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and …
R Ramanathan, H Choudry, H Jones… - Annals of Surgical …, 2021 - europepmc.org
Background Peritoneal metastases portend poor prognosis in the setting of standard
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …
chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …